A simple nomogram prediction model to identify relatively young patients with mild cognitive impairment who may

Wenhong Chen1, Songtao Li1, Yangyang Ma1

  • 1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.

Abstract

Insights

A new predictive model identifies younger patients with mild cognitive impairment (MCI) who may develop Alzheimer's disease (AD). This tool combines clinical data and brain imaging for early screening and intervention.

Area of Science:

  • Neurology
  • Neuroimaging
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD).
  • Early identification of MCI patients at high risk for AD progression is crucial for timely intervention.
  • Predictive models can aid clinicians in stratifying risk within younger MCI populations.

Purpose of the Study:

  • To develop a clinical predictive model for identifying MCI patients (≤65 years) likely to progress to AD.
  • To integrate easily accessible clinical features with structural neuroimaging data for enhanced prediction.
  • To validate the model's performance in a distinct patient cohort.

Main Methods:

  • Utilized data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.
  • Selected MCI patients ≤65 years with 6-60 months follow-up.
  • Extracted demographic, neuropsychological, and structural MRI data.
  • Performed voxel-based morphometry (VBM) and surface-based morphometry (SBM) analyses.
  • Constructed predictive models combining clinical and imaging features.

Main Results:

  • The developed nomogram achieved a cross-validated AUC of 0.872 (training set) and 0.867 (verification set).
  • Calibration curves demonstrated good model fit.
  • An online forecasting tool based on the model is available.

Conclusions:

  • The predictive model demonstrates strong performance and ease of use.
  • This tool can assist clinicians in screening younger MCI patients at risk of progressing to AD.
  • Facilitates earlier detection and potential therapeutic strategies for at-risk individuals.